Recurrence of Lentigo Maligna and Development of Invasive Melanoma after Treatment of Lentigo Maligna with Imiquimod

被引：28
作者：
Woodmansee, Courtney S. [1 ,2 ]
McCall, Michael W. [1 ,2 ]
机构：
[1] Associates Dermatol PLLC, Louisville, KY USA
[2] Univ Louisville, Dept Med, Div Dermatol, Louisville, KY 40292 USA
来源：
DERMATOLOGIC SURGERY | 2009年 / 35卷 / 08期
关键词：
IN-SITU; CREAM; SKIN;
D O I：
10.1111/j.1524-4725.2009.01227.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
The authors have indicated no significant interest with commercial supporters.
引用
收藏
页码：1286 / 1289
页数：4
相关论文
共 6 条
[1]   Treatment of lentigo maligna with imiquimod before staged excision [J].
Cotter, Murray A. ;
McKenna, Jeffrey K. ;
Bowen, Glen M. .
DERMATOLOGIC SURGERY, 2008, 34 (02) :147-151
[2]   Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease [J].
Fisher, GH ;
Lang, PG .
ARCHIVES OF DERMATOLOGY, 2003, 139 (07) :945-947
[3]   Treatment of lentigo maligna with topical imiquimod [J].
Naylor, MF ;
Crowson, N ;
Kuwahara, R ;
Teague, K ;
Garcia, C ;
Mackinnis, C ;
Haque, R ;
Odom, C ;
Jankey, C ;
Cornelison, RL .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 :66-69
[4]   Recurrence of lentigo maligna after initial complete response to treatment with 5% imiquimod cream [J].
van Meurs, T. ;
van Doorn, R. ;
Kirtschig, G. .
DERMATOLOGIC SURGERY, 2007, 33 (05) :623-627
[5]   Treatment of lentigo Maligna (melanoma in situ) with the immune response modifier imiquimod [J].
Wolf, IH ;
Cerroni, L ;
Kodama, K ;
Kerl, H .
ARCHIVES OF DERMATOLOGY, 2005, 141 (04) :510-514
[6]   The role of topical immune response modifiers in skin cancer [J].
Woodmansee, Courtney ;
Pillow, Jessica ;
Skinner, Robert B., Jr. .
DRUGS, 2006, 66 (13) :1657-1664
1